Table 4 Patient opinions on the trial of FED monotherapy after achieving histologic remission of EoE with PPI monotherapy
Survey responses | Patients with histologic remission of EoE on PPI monotherapy and FED monotherapy (n = 9) | Patients with histologic remission of EoE on PPI monotherapy but not FED monotherapy (n = 6) | All patients (n = 15) |
|---|---|---|---|
Question: After finding out that your EoE was responsive to PPI therapy, why did you choose to undergo a FED and repeat EGD? | |||
Concerned about long-term medication usage | 5 (55.56%) | 4 (66.67%) | 9 (60%) |
Suspected side effects of PPI | 1 (11.11%) | 1 (16.67%) | 2 (13.33%) |
Wanted to discover food triggers | 2 (22.22%) | 1 (16.67%) | 3 (20%) |
Wanted options for future treatment | 1 (11.11%) | 0 (0%) | 1 (6.67%) |
Question: Would you recommend this process for someone else with EoE? | |||
Yes | 8 (88.89%) | 6 (100%) | 14 (93.33%) |
Question: Would you personally go through this process again? | |||
Yes | 8 (88.89%) | 4 (66.67%) | 12 (80%) |